1. Home
  2. GPCR vs BOW Comparison

GPCR vs BOW Comparison

Compare GPCR & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • BOW
  • Stock Information
  • Founded
  • GPCR 2016
  • BOW 2020
  • Country
  • GPCR United States
  • BOW United States
  • Employees
  • GPCR N/A
  • BOW N/A
  • Industry
  • GPCR
  • BOW Property-Casualty Insurers
  • Sector
  • GPCR
  • BOW Finance
  • Exchange
  • GPCR Nasdaq
  • BOW Nasdaq
  • Market Cap
  • GPCR 1.1B
  • BOW 1.1B
  • IPO Year
  • GPCR 2023
  • BOW 2024
  • Fundamental
  • Price
  • GPCR $20.91
  • BOW $28.12
  • Analyst Decision
  • GPCR Strong Buy
  • BOW Buy
  • Analyst Count
  • GPCR 9
  • BOW 6
  • Target Price
  • GPCR $75.63
  • BOW $38.33
  • AVG Volume (30 Days)
  • GPCR 1.1M
  • BOW 316.8K
  • Earning Date
  • GPCR 11-12-2025
  • BOW 11-04-2025
  • Dividend Yield
  • GPCR N/A
  • BOW N/A
  • EPS Growth
  • GPCR N/A
  • BOW 41.97
  • EPS
  • GPCR N/A
  • BOW 1.47
  • Revenue
  • GPCR N/A
  • BOW $492,071,000.00
  • Revenue This Year
  • GPCR N/A
  • BOW $23.14
  • Revenue Next Year
  • GPCR N/A
  • BOW $25.19
  • P/E Ratio
  • GPCR N/A
  • BOW $19.11
  • Revenue Growth
  • GPCR N/A
  • BOW 41.21
  • 52 Week Low
  • GPCR $13.22
  • BOW $27.07
  • 52 Week High
  • GPCR $45.37
  • BOW $42.29
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 58.61
  • BOW 28.43
  • Support Level
  • GPCR $18.49
  • BOW $28.64
  • Resistance Level
  • GPCR $22.25
  • BOW $32.26
  • Average True Range (ATR)
  • GPCR 1.16
  • BOW 0.84
  • MACD
  • GPCR 0.15
  • BOW -0.22
  • Stochastic Oscillator
  • GPCR 66.38
  • BOW 0.72

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About BOW Bowhead Specialty Holdings Inc. Common Stock

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

Share on Social Networks: